Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept for PCV Without Active Polyps
NCT02072408Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Feb 2014
- Primary completion
- Nov 2017
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in polypoidal choroidal vasculopathy (PCV), sponsored by Samsung Medical Center. Started Feb 2014; status: completed.
02
Drugs
aflibercept
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT02072408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02072408.